Перевести на Переведено сервисом «Яндекс.Перевод»

Heartware International Inc.

Phone
(508) 739-09-50
Country
USA
Headquarters
500 Old Connecticut Path Framingham, MA 01701
Ticker
NASDAQ:HTWR
Description

Few advancements in healthcare today have as big an impact on heart failure as ventricular assist devices (VADs). Where once patients with heart failure were confined to their homes or hospitals, unable to actively participate in their lives, VADs now allow a longer, healthier and more normal life. As a result, the use of VADs has increased. Worldwide, approximately 36% of the estimated 50,000 patients waiting for heart transplantation are bridged-to-transplant.

Despite their growing adoption, VADs have been implanted in very few patients who could benefit from this life-saving therapy. A likely cause? The infrastructure and expertise required to support patients who need a VAD is extraordinarily high.

Today, very few hospitals worldwide offer options such as VADs or transplants for patients with advanced heart failure. More often than not, these hospitals face capacity constraints due to the increased number of patients in need.

As a leader in VAD support, HeartWare is committed to partnering with clinicians to help patients gain access to our technology.